OBJECTIVE: Mast cell and basophil activation contributes to inflammation, bronchoconstriction, and airway hyperresponsiveness in asthma. Because IL-33 expression is inflammation inducible, we investigated IL-33-mediated effects in concert with both IgE-mediated and IgE-independent stimulation. METHODS: Because the HMC-1 mast cell line can be activated by GPCR and RTK signaling, we studied the effects of IL-33 on these pathways. The IL-33- and SCF-stimulated HMC-1 cells were co-cultured with human lung fibroblasts and airway smooth muscle cells in a collagen gel contraction assay. IL-33 effects on IgE-mediated activation were studied in primary mast cells and basophils. RESULT: IL-33 synergized with adenosine, C5a, SCF, and NGF receptor activation. IL-33-stimulated and SCF-stimulated HMC-1 cells demonstrated enhanced collagen gel contraction when cultured with fibroblasts or smooth muscle cells. IL-33 also synergized with IgE receptor activation of primary human mast cells and basophils. CONCLUSION: IL-33 amplifies inflammation in both IgE-independent and IgE-dependent responses.
OBJECTIVE: Mast cell and basophil activation contributes to inflammation, bronchoconstriction, and airway hyperresponsiveness in asthma. Because IL-33 expression is inflammation inducible, we investigated IL-33-mediated effects in concert with both IgE-mediated and IgE-independent stimulation. METHODS: Because the HMC-1 mast cell line can be activated by GPCR and RTK signaling, we studied the effects of IL-33 on these pathways. The IL-33- and SCF-stimulated HMC-1 cells were co-cultured with human lung fibroblasts and airway smooth muscle cells in a collagen gel contraction assay. IL-33 effects on IgE-mediated activation were studied in primary mast cells and basophils. RESULT: IL-33 synergized with adenosine, C5a, SCF, and NGF receptor activation. IL-33-stimulated and SCF-stimulated HMC-1 cells demonstrated enhanced collagen gel contraction when cultured with fibroblasts or smooth muscle cells. IL-33 also synergized with IgE receptor activation of primary human mast cells and basophils. CONCLUSION:IL-33 amplifies inflammation in both IgE-independent and IgE-dependent responses.
Authors: Andrea Bree; Franklin J Schlerman; Michael Wadanoli; Lioudmila Tchistiakova; Kimberly Marquette; Xiang-Yang Tan; Bruce A Jacobson; Angela Widom; Timothy A Cook; Nancy Wood; Suresh Vunnum; Rustem Krykbaev; Xin Xu; Debra D Donaldson; Samuel J Goldman; Joseph Sypek; Marion T Kasaian Journal: J Allergy Clin Immunol Date: 2007-03-26 Impact factor: 10.793
Authors: Gaby Palmer; Brian P Lipsky; Molly D Smithgall; David Meininger; Sophia Siu; Dominique Talabot-Ayer; Cem Gabay; Dirk E Smith Journal: Cytokine Date: 2008-05-02 Impact factor: 3.861
Authors: Shafaqat Ali; Michael Huber; Christian Kollewe; Stephan C Bischoff; Werner Falk; Michael U Martin Journal: Proc Natl Acad Sci U S A Date: 2007-11-14 Impact factor: 11.205
Authors: Johann Wojta; Christoph Kaun; Gerlinde Zorn; Minoo Ghannadan; Alexander W Hauswirth; Wolfgang R Sperr; Gerhard Fritsch; Dieter Printz; Bernd R Binder; Georg Schatzl; Joerg Zwirner; Gerald Maurer; Kurt Huber; Peter Valent Journal: Blood Date: 2002-07-15 Impact factor: 22.113
Authors: M Ali; G Zhang; W R Thomas; C J McLean; J A Bizzintino; I A Laing; A C Martin; J Goldblatt; P N Le Souëf; C M Hayden Journal: Tissue Antigens Date: 2009-03
Authors: Victor S Ndaw; Daniel Abebayehu; Andrew J Spence; Patrick A Paez; E Motunrayo Kolawole; Marcela T Taruselli; Heather L Caslin; Alena P Chumanevich; Anuya Paranjape; Bianca Baker; Brian O Barnstein; Tamara T Haque; Kasalina N Kiwanuka; Carole A Oskeritzian; John J Ryan Journal: J Immunol Date: 2017-06-21 Impact factor: 5.422
Authors: Alexandra Taracanova; Irene Tsilioni; Pio Conti; Errol R Norwitz; Susan E Leeman; Theoharis C Theoharides Journal: Proc Natl Acad Sci U S A Date: 2018-09-19 Impact factor: 11.205
Authors: Mi-Yeon Jung; Daniel Smrž; Avanti Desai; Geethani Bandara; Tomonobu Ito; Shoko Iwaki; Jeong-Han Kang; Marcus V Andrade; Susana C Hilderbrand; Jared M Brown; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan Journal: J Immunol Date: 2012-12-17 Impact factor: 5.422
Authors: Geethani Bandara; Michael A Beaven; Ana Olivera; Alasdair M Gilfillan; Dean D Metcalfe Journal: Eur J Immunol Date: 2015-09-09 Impact factor: 5.532